These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2100565)
1. Markers of central nervous system tumors. Birkmayer GD Immunol Ser; 1990; 53():317-22. PubMed ID: 2100565 [No Abstract] [Full Text] [Related]
2. Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors. Bullard DE; Bigner DD J Neurosurg; 1985 Jul; 63(1):2-16. PubMed ID: 2409248 [TBL] [Abstract][Full Text] [Related]
3. Glioma proteomics: status and perspectives. Niclou SP; Fack F; Rajcevic U J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038 [TBL] [Abstract][Full Text] [Related]
4. Tumor markers: malignin and related recognins associated with malignancy rather than with cell type. Bogoch S; Bogoch ES Prog Clin Biol Res; 1980; 39():407-24. PubMed ID: 7403189 [No Abstract] [Full Text] [Related]
5. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma. Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615 [TBL] [Abstract][Full Text] [Related]
6. Human glioma associated and related antigens, identified by monoclonal antibodies. Yoshida J; Kageyama N; Ueda R; Takahashi T Neurosurg Rev; 1984; 7(1):23-8. PubMed ID: 6205324 [TBL] [Abstract][Full Text] [Related]
7. A preliminary study of brain gliomas with H17E2 monoclonal antibody: immunoscintigraphy and pharmacokinetics. Skarlos DV; Malamitsi J; Sivolapenko GB; Demakopoulos N; Avgoustatos G; Koutoulidis C; Epenetos AA Int J Biol Markers; 1989; 4(3):135-41. PubMed ID: 2614081 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies: their application in the diagnosis and management of CNS tumors. de Tribolet N; Frank E; Mach JP Clin Neurosurg; 1988; 34():446-56. PubMed ID: 3288406 [No Abstract] [Full Text] [Related]
10. Immunopathological investigation of human glioma-associated antigen (GAA) detected by monoclonal antibody. Tu YC; Lee WH; Yeh MY; Han SH; Wang YC; Shih CJ Zhonghua Yi Xue Za Zhi (Taipei); 1988 Feb; 41(2):89-96. PubMed ID: 3167663 [No Abstract] [Full Text] [Related]
11. The use of monoclonal antibodies in the immunohistological diagnosis of cerebral and spinal tumours. Coakham HB; Garson JA; Brownell B; Allan PM; Harper EI; Kemshead JT S Afr J Surg; 1984; 22(1):13-22. PubMed ID: 6372129 [No Abstract] [Full Text] [Related]
13. Cerebral and spinal cord myxopapillary ependymomas: a case report. al Moutaery K; Aabed MY; Ojeda VJ Pathology; 1996 Nov; 28(4):373-6. PubMed ID: 9007962 [TBL] [Abstract][Full Text] [Related]
14. High expression and frequently humoral immune response of melanoma-associated antigen D4 in glioma. He SJ; Gu YY; Yu L; Luo B; Fan R; Lin WZ; Lan XW; Lin YD; Zhang QM; Xiao SW; Xie XX Int J Clin Exp Pathol; 2014; 7(5):2350-60. PubMed ID: 24966945 [TBL] [Abstract][Full Text] [Related]
15. Detection of MAGE-1 tumor antigen in brain tumor. Kuramoto T Kurume Med J; 1997; 44(1):43-51. PubMed ID: 9154761 [TBL] [Abstract][Full Text] [Related]
16. Contrast enhancement in primary tumors of the brain and spinal cord. Castillo M Neuroimaging Clin N Am; 1994 Feb; 4(1):63-80. PubMed ID: 8130953 [TBL] [Abstract][Full Text] [Related]
18. Immunological reactions to gliomas. Ridley A Mod Trends Neurol; 1975; 6():249-66. PubMed ID: 1105142 [No Abstract] [Full Text] [Related]
19. The use of monoclonal antibodies for the diagnosis of intracranial malignancies and the small round cell tumours of childhood. Kemshead JT; Coakham HB J Pathol; 1983 Nov; 141(3):249-57. PubMed ID: 6663388 [TBL] [Abstract][Full Text] [Related]